Literature DB >> 16208694

Clinical features of 78 adults with 22q11 Deletion Syndrome.

Anne S Bassett1, Eva W C Chow, Janice Husted, Rosanna Weksberg, Oana Caluseriu, Gary D Webb, Michael A Gatzoulis.   

Abstract

22q11 Deletion Syndrome (22q11DS) is a common microdeletion syndrome with multisystem expression. Phenotypic features vary with age, ascertainment, and assessment. We systematically assessed 78 adults (36 M, 42 F; mean age 31.5, SD 10.5 years) with a 22q11.2 deletion ascertained through an adult congenital cardiac clinic (n = 35), psychiatric-related sources (n = 39), or as affected parents of subjects (n = 4). We recorded the lifetime prevalence of features requiring attention, with 95% confidence intervals (CI) not overlapping zero. Subtle learning difficulties, hypernasality and facial gestalt were not included. We investigated ascertainment effects using non-overlapping subgroups ascertained with tetralogy of Fallot (n = 31) or schizophrenia (n = 31). Forty-three features met inclusion criteria and were present in 5% or more patients, including several of later onset (e.g., hypothyroidism, cholelithiasis). Number of features per patient (median 9, range 3-22) correlated with hospitalizations (P = 0.0002) and, when congenital features were excluded, with age (P = 0.02). Adjusting for ascertainment, 25.8% (95% CI, 9.5-42.1%) of patients had cardiac anomalies and 22.6% (95% CI, 7.0-38.2%) had schizophrenia. Ascertainment subgroups were otherwise similar in median number and prevalence of features. Non-characteristic features are common in 22q11DS. Adjusting for ascertainment effects is important. Many treatable conditions may be anticipated and features may accumulate over time. The results have implications for clinical assessment and management, genetic counseling and research into pathophysiological mechanisms. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2005        PMID: 16208694      PMCID: PMC3127862          DOI: 10.1002/ajmg.a.30984

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  37 in total

1.  Velopharyngeal incompetence and chromosome 22q11 deletion.

Authors:  J G Boorman; S Varma; C M Ogilvie
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

Review 2.  Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications.

Authors:  A Swillen; A Vogels; K Devriendt; J P Fryns
Journal:  Am J Med Genet       Date:  2000

3.  Users' guides to the medical literature: XXIV. How to use an article on the clinical manifestations of disease. Evidence-Based Medicine Working Group.

Authors:  W S Richardson; M C Wilson; J W Williams; V A Moyer; C D Naylor
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

Review 4.  Chromosomal abnormalities and schizophrenia.

Authors:  A S Bassett; E W Chow; R Weksberg
Journal:  Am J Med Genet       Date:  2000

5.  Presenting phenotype in 100 children with the 22q11 deletion syndrome.

Authors:  Sólveig Oskarsdóttir; Christina Persson; Bengt O Eriksson; Anders Fasth
Journal:  Eur J Pediatr       Date:  2004-11-23       Impact factor: 3.183

Review 6.  Genetic counselling for schizophrenia in the era of molecular genetics.

Authors:  K A Hodgkinson; J Murphy; S O'Neill; L Brzustowicz; A S Bassett
Journal:  Can J Psychiatry       Date:  2001-03       Impact factor: 4.356

7.  Tetralogy of Fallot associated with chromosome 22q11.2 deletion in adolescents and young adults.

Authors:  K Momma; A Takao; R Matsuoka; Y Imai; A Muto; M Osawa; M Takayama
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

8.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!

Authors:  D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

Review 9.  Endocrine aspects of the 22q11.2 deletion syndrome.

Authors:  S A Weinzimer
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

10.  Auxological evaluation in patients with DiGeorge/velocardiofacial syndrome (deletion 22q11.2 syndrome).

Authors:  M C Digilio; B Marino; M Cappa; P Cambiaso; A Giannotti; B Dallapiccola
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  160 in total

1.  Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome.

Authors:  G Costain; E W C Chow; P N Ray; A S Bassett
Journal:  J Intellect Disabil Res       Date:  2011-12-06

Review 2.  The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan.

Authors:  Rachel K Jonas; Caroline A Montojo; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

3.  Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.

Authors:  Cynthia B Solot; Tyler M Moore; Terrence Blaine Crowley; Marsha Gerdes; Edward Moss; Daniel E McGinn; Beverly S Emanuel; Elaine H Zackai; Sean Gallagher; Monica E Calkins; Kosha Ruparel; Ruben C Gur; Donna M McDonald-McGinn; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-07-27       Impact factor: 3.568

4.  Neurocognitive profile in 22q11 deletion syndrome and schizophrenia.

Authors:  Eva W C Chow; Mark Watson; Donald A Young; Anne S Bassett
Journal:  Schizophr Res       Date:  2006-06-06       Impact factor: 4.939

5.  Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome.

Authors:  Rosanna Weksberg; Andrea C Stachon; Jeremy A Squire; Laura Moldovan; Jane Bayani; Stephen Meyn; Eva Chow; Anne S Bassett
Journal:  Hum Genet       Date:  2006-10-07       Impact factor: 4.132

6.  Recognizing a common genetic syndrome: 22q11.2 deletion syndrome.

Authors:  Ronak K Kapadia; Anne S Bassett
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

7.  The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome.

Authors:  Christina Zaleski; Anne S Bassett; Karen Tam; Andrea L Shugar; Eva W C Chow; Elizabeth McPherson
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

8.  Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.

Authors:  Maria Suntsova; Elena V Gogvadze; Sergey Salozhin; Nurshat Gaifullin; Fedor Eroshkin; Sergey E Dmitriev; Natalia Martynova; Kirill Kulikov; Galina Malakhova; Gulnur Tukhbatova; Alexey P Bolshakov; Dmitry Ghilarov; Andrew Garazha; Alexander Aliper; Charles R Cantor; Yuri Solokhin; Sergey Roumiantsev; Pavel Balaban; Alex Zhavoronkov; Anton Buzdin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 9.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models.

Authors:  Hanna Jaaro-Peled; Yavuz Ayhan; Mikhail V Pletnikov; Akira Sawa
Journal:  Schizophr Bull       Date:  2009-11-10       Impact factor: 9.306

10.  Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Thomas R Kwapil; Jessica Kaczorowski; Margaret N Berry; Cesar S Santos; Timothy D Howard; Dhruman Goradia; Konasale Prasad; Diwadkar Vaibhav; Rajaprabhakaran Rajarethinam; Edward Spence; Matcheri S Keshavan
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.